Using Botulinum Toxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome—Possible Pathomechanisms and Practical Issues
Treatment for patients with interstitial cystitis/bladder pain syndrome (IC/BPS) is always challenging for urologists. The main mechanism of the botulinum toxin A (BoNT-A) is inhibition of muscle contraction, but the indirect sensory modulation and anti-inflammatory effect in the bladder also play i...
Main Author: | Jia-Fong Jhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/11/11/641 |
Similar Items
-
Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis
by: Bin Chiu, et al.
Published: (2016-07-01) -
Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
by: Jing-Liang Chen, et al.
Published: (2020-02-01) -
BOTULINUM TOXIN A FOR THE MANAGEMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME
by: V. L. Medvedev, et al.
Published: (2017-10-01) -
Effect of Botulinum Toxin A on Bladder Pain—Molecular Evidence and Animal Studies
by: Ting-Chun Yeh, et al.
Published: (2020-02-01) -
Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction
by: Joseph J. Janicki, et al.
Published: (2016-03-01)